Vistin Pharma As, based in Sweden, is a pharmaceutical company.
One of their notable products is METFORMIN HYDROCHLORIDE, with a corresponding US DMF Number 19190.
Remarkably, this DMF maintains an Active status since its submission on February 17, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 01, 2014, and payment made on September 19, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II